keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DALDA TFA is a potent, μ-opioid receptor agonist exhibiting high selectivity and an affinity constant (K i) of 1.69 nM. It demonstrates antinociceptive properties and influences respiratory functions [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | DALDA TFA is a potent, μ-opioid receptor agonist exhibiting high selectivity and an affinity constant (K i) of 1.69 nM. It demonstrates antinociceptive properties and influences respiratory functions [1]. |
In vitro | DALDA possesses a net positive charge of 3+ at physiological pH, making it hydrophilic and increasing its polarity relative to morphine [1]. |
In vivo | DALDA administered intrathecally at doses ranging from 0 to 7 nmol/rat exhibits both antinociceptive and respiratory effects in rats [1]. When delivered intracerebroventricularly at 0.1 and 1.0 μg/side, DALDA induces a biphasic response characterized by initial suppression, then pronounced inhibition, and subsequent activation of horizontal movement, rearing, and stereotypy behaviors in rats [2]. |
Molecular Weight | 611.74 (free base) |
Formula | C30H45N9O5.xC2HF3O2 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DALDA TFA Endocrinology/Hormones GPCR/G Protein Neuroscience Opioid Receptor inhibitor inhibit